Faheem Hasnain on stage at the Endpoints News / PharmCube #BIIS18 summit in Shanghai (Endpoints News)

April 25, 2022 09:07 AM EDT

Faheem Hasnain acknowledges another setback for the Gossamer pipeline, but investors aren't panicking

Faheem Hasnain’s attempt to break new ground in treating ulcerative colitis at Gossamer Bio has broken down at the Phase II finish line.

The biotech …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Fa­heem Has­nain ac­knowl­edges an­oth­er set­back for the Gos­samer pipeline, but in­vestors aren't pan­ick­ing